Literature DB >> 15618168

Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.

Nancy Walters1, Theresa Trunkle, Michael Sura, David W Pascual.   

Abstract

The development of the neurokinin-1 receptor-deficient (NK1R(-/-)) mouse permitted inquiry into the regulation of secretory immunoglobulin A (S-IgA) responses by substance P (SP) after oral immunization with a Salmonella enterica serovar Typhimurium vector expressing colonization factor antigen I (CFA/I) from enterotoxigenic Escherichia coli. In NK1R(-/-) mice, mucosal and serum IgA anti-CFA/I fimbrial responses were augmented, while secreted IgG anti-CFA/I fimbrial responses remained unaffected compared to those of BALB/c (NK1R(+/+)) mice. Supportive antibody-forming cells were present in the small intestinal lamina propria and spleen. To gain insight as to why the augmented S-IgA responses occurred, minimally, the responses were not attributed to differences in vaccine colonization of Peyer's patch (PP) and spleen or in their respective tissue weights. However, these S-IgA responses were supported by increased numbers of PP CD4(+) T helper (Th) cells secreting interleukin-5 (IL-5) and IL-6 and splenic CD4(+) Th cells secreting IL-6 compared to NK1R(+/+) mice. Challenge of naive NK1R(-/-) mice with wild-type Salmonella showed improved median survival compared to naive NK1R(+/+) mice. Data from peritoneal macrophage infection studies suggest that this survival is in part contributed by increased IL-10 production. Oral vaccination with Salmonella CFA/I or Salmonella vector showed no significant differences in conferred protection against wild-type challenge for either NK1R(-/-) or NK1R(+/+) mice. Thus, these studies suggest that SP mediation contributes to proinflammatory responses to Salmonella infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618168      PMCID: PMC538984          DOI: 10.1128/IAI.73.1.317-324.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum.

Authors:  S Ichikawa; S P Sreedharan; E J Goetzl; R L Owen
Journal:  Regul Pept       Date:  1994-12-15

2.  Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli.

Authors:  R H Hall; D R Maneval; J H Collins; J L Theibert; M M Levine
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

3.  Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells.

Authors:  K W Beagley; J H Eldridge; H Kiyono; M P Everson; W J Koopman; T Honjo; J R McGhee
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

4.  Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908.

Authors:  J A Girón; J G Xu; C R González; D Hone; J B Kaper; M M Levine
Journal:  Vaccine       Date:  1995-07       Impact factor: 3.641

5.  Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.

Authors:  D W Pascual; J C Xu-Amano; H Kiyono; J R McGhee; K L Bost
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

6.  Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.

Authors:  R Schafer; D A Portnoy; S A Brassell; Y Paterson
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

7.  Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.

Authors:  S Wu; D W Pascual; J L VanCott; J R McGhee; D R Maneval; M M Levine; D M Hone
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.

Authors:  F R Noriega; G Losonsky; J Y Wang; S B Formal; M M Levine
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

10.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.

Authors:  K W Beagley; J H Eldridge; F Lee; H Kiyono; M P Everson; W J Koopman; T Hirano; T Kishimoto; J R McGhee
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  17 in total

1.  Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.

Authors:  Xinghong Yang; Zhiyong Suo; Theresa Thornburg; Kathryn Holderness; Ling Cao; Timothy Lim; Nancy Walters; Laura Kellerman; Linda Loetterle; Recep Avci; David W Pascual
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

Review 2.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

Review 3.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 4.  Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.

Authors:  Felipe A Pinho-Ribeiro; Waldiceu A Verri; Isaac M Chiu
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

5.  Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.

Authors:  Sangmu Jun; Javier Ochoa-Repáraz; Dagmara Zlotkowska; Teri Hoyt; David W Pascual
Journal:  J Neuroimmunol       Date:  2012-03-13       Impact factor: 3.478

6.  Selection of protective epitopes for Brucella melitensis by DNA vaccination.

Authors:  Xinghong Yang; Mary Hudson; Nancy Walters; Robert F Bargatze; David W Pascual
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells.

Authors:  Irina Kochetkova; Theresa Trunkle; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  Increased susceptibility of melanin-concentrating hormone-deficient mice to infection with Salmonella enterica serovar Typhimurium.

Authors:  Apostolos K A Karagiannis; Dimitrios C Ziogas; Beatriz Gras-Miralles; Brenda M Geiger; Jutta Nagel; Estela Trebicka; Robert Najarian; Bobby J Cherayil; Efi Kokkotou
Journal:  Infect Immun       Date:  2012-10-31       Impact factor: 3.441

Review 9.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 10.  Pain and immunity: implications for host defence.

Authors:  Pankaj Baral; Swalpa Udit; Isaac M Chiu
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.